Select for export Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experience Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX BJPsych Open 2024-10-31 Mourad Wahba, Caroline Hayes, Maartje Kletter, R. Hamish McAllister-Williams OpenAlex Published psilocybin DepressionChronic PainPharmacology Clinical Trial More
Select for export Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241287542 PubMed 39480198 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-10-30 Sepehr Aghajanian, Arman Shafiee, Samira Parvizi Omran, Aida Rezaei Nejad, Kyana Jafarabady, Omid Kohandel Gargari OpenAlex Published psilocybin DepressionChronic PainReceptor Pharmacology Randomized Controlled Trial More
Select for export A narrative exploration of psilocybin's potential in mental health. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2024.1429373 PubMed 39540010 Copy citation Copy BibTeX Unknown journal 2024-10-29 Min H, Park SY, Park J, Na S, Lee HS, Kim T Europe PMC Published psilocybin Mechanism of ActionClinical TrialReview Article Clinical Trial More
Select for export Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey study No abstract availability was recorded for this entry. Details DOI 10.1016/j.jad.2024.10.058 PubMed 39447981 Copy citation Copy BibTeX Journal of Affective Disorders 2024-10-21 Grant Jones, Matthew X. Lowe, Sandeep M. Nayak, Nathan D. Sepeda, Hannes Kettner, Robin Carhart-Harris OpenAlex Published psilocybin Chronic PainObservational Study Observational Study More
Select for export The therapeutic potential and mechanisms of action of psilocybin-assisted therapy in anorexia nervosa treatment Abstract available at the source but not redistributed here. Read at source. Details DOI 10.25560/118978 Copy citation Copy BibTeX Open MIND 2024-10-09 Hannah Douglass OpenAlex Published psilocybin DepressionAnxietyEating Disorders Observational Study More
Select for export Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/head.14846 PubMed 39382331 Copy citation Copy BibTeX Headache The Journal of Head and Face Pain 2024-10-08 James Rucker, Matthew Butler, Sadie Hambleton, Catherine Bird, Mathieu Seynaeve, Sanjay Cheema OpenAlex Published psilocybin Chronic PainHeadache / MigrainePharmacology Clinical Trial More
Select for export Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241282637 PubMed 39340164 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-09-26 Daniel Meling, Klemens Egger, Helena Aicher, Javier Jareño Redondo, Jovin Mueller, Joëlle Dornbierer OpenAlex Published psilocybin Chronic PainWellbeingEmotional Processing Clinical Trial More
Select for export Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study No abstract availability was recorded for this entry. Details DOI 10.1016/j.jad.2024.09.133 PubMed 39343309 Copy citation Copy BibTeX Journal of Affective Disorders 2024-09-26 Sara Ellis, Catherine Bostian, Wendy Feng, E. Grace Fischer, Garrett Schwartz, Katherine Eisen OpenAlex Published psilocybin DepressionChronic PainClinical Trial Clinical Trial More
Select for export Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.eclinm.2024.102799 PubMed 39764567 Copy citation Copy BibTeX EClinicalMedicine 2024-09-22 David Erritzøe, Tommaso Barba, Kyle T. Greenway, Roberta Murphy, Jonny Martell, Bruna Giribaldi OpenAlex Published psilocybin DepressionAnxietyChronic Pain Randomized Controlled Trial More
Select for export Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241278873 PubMed 39302087 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-09-19 Abigail E. Calder, Benjamin Rausch, Matthias E. Liechti, Friederike Holze, Gregor Hasler OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/head.14837 PubMed 39301810 Copy citation Copy BibTeX Headache The Journal of Head and Face Pain 2024-09-19 James Rucker, Matthew Butler, Sadie Hambleton, Catherine Bird, Mathieu Seynaeve, Sanjay Cheema OpenAlex Published psilocybin Chronic PainHeadache / MigrainePharmacology Clinical Trial More
Select for export B - 61 Psilocybin as a First-Line Treatment of ADHD in Adult Populations Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/arclin/acae067.222 Copy citation Copy BibTeX Archives of Clinical Neuropsychology 2024-09-11 James Perry, Cara C. Young, Julie Williams OpenAlex Published psilocybin NeuroplasticityPharmacologyReceptor Pharmacology Review Article More
Select for export Psychoactive substances for the treatment of neuropsychiatric disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.ajp.2024.104193 PubMed 39243659 Copy citation Copy BibTeX Unknown journal 2024-09-02 Zhen Z, Sun X, Yuan S, Zhang J. Europe PMC Published psilocybin DepressionAnxietyPTSD Review Article More
Select for export G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1136/rapm-2024-esra.582 Copy citation Copy BibTeX Unknown journal 2024-08-31 Amany E. Ayad OpenAlex Published psilocybin DepressionPTSDAddiction Randomized Controlled Trial More
Select for export Traditional Medicine, Culture, and Psychedelic Science: New Pathways for Recovery From Substance Use Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.15288/jsad.23-00011 PubMed 39400118 Copy citation Copy BibTeX Unknown journal 2024-08-31 Loizaga-Velder A, Loizaga Pazzi A. Europe PMC Published psilocybin AddictionMechanism of ActionConsciousness Review Article More
Select for export Refractory CRPS pain treated with psilocybin: A case report Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/ccr3.9421 PubMed 39281029 Copy citation Copy BibTeX Clinical Case Reports 2024-08-31 David S. Jevotovsky, Harman Chopra, Court Wing, Carlton J. Spotswood, Joel Castellanos OpenAlex Published psilocybin Chronic PainPharmacologyMechanism of Action Case Report More
Select for export Mystical Experience with Cancer Patients: Insights from Psychedelic-Assisted Psychotherapy and Guided Imagery Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31579/2834-8761/056 Copy citation Copy BibTeX Clinical Endocrinology and Metabolism 2024-08-29 Jerry B. Brown *, Julie M. Brown OpenAlex Published psilocybin End-of-Life DistressChronic PainEmotional Processing Other More
Select for export Psychedelics, Psychedelic-Assisted Therapy and Employees’ Wellbeing Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/10564926241267208 Copy citation Copy BibTeX Journal of Management Inquiry 2024-08-27 Charlotte Smith OpenAlex Published psilocybin Receptor PharmacologyAgingWellbeing Other More
Select for export Psychedelic use and psychological flexibility: The role of meaningful intention and decentering Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1556/2054.2024.00350 Copy citation Copy BibTeX Journal of Psychedelic Studies 2024-08-15 William M. Campo, Ann Marie Yali OpenAlex Published psilocybin Mechanism of ActionReceptor PharmacologyWellbeing Observational Study More
Select for export From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241265762 PubMed 39075756 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-07-28 Claire Walker, Timothy Piatkowski, Jason Ferris, Emma Davies, Monica J. Barratt, Adam Winstock OpenAlex Published psilocybin DepressionAnxietyAddiction Observational Study More
